FR2372841A1 - Gamma-globuline injectable par voie intraveineuse - Google Patents

Gamma-globuline injectable par voie intraveineuse

Info

Publication number
FR2372841A1
FR2372841A1 FR7736336A FR7736336A FR2372841A1 FR 2372841 A1 FR2372841 A1 FR 2372841A1 FR 7736336 A FR7736336 A FR 7736336A FR 7736336 A FR7736336 A FR 7736336A FR 2372841 A1 FR2372841 A1 FR 2372841A1
Authority
FR
France
Prior art keywords
globulin
gamma
concentration
volume
temperatures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7736336A
Other languages
English (en)
Other versions
FR2372841B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COVAL MYER
Original Assignee
COVAL MYER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COVAL MYER filed Critical COVAL MYER
Publication of FR2372841A1 publication Critical patent/FR2372841A1/fr
Application granted granted Critical
Publication of FR2372841B1 publication Critical patent/FR2372841B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/85Reproductive organs or embryos
    • Y10S530/851Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention a pour objet une nouvelle gamma-globuline présentant une activité anticomplémentaire très faible tout en conservant un spectre d'activite très large. Le procédé de préparation de cette gamma-globuline consiste à extraire une pâte des fractions II ou II + III de Cohn ou de l'extrait placentaire les renfermant avec de l'eau apyrogène, à un pH de 4,9 à 6, à traiter ensuite l'extrait filtré avec du polyéthylèneglycol jusqu'à ce qu'on obtienne une concentration de 4 % (poids/volume), puis à ajouter de l'éthanol jusqu'à ce qu'on obtienne une concentration de 4 à 12 % (poids/volume) à des températures comprises entre - 6 et + 10 degrés C, en séparant chaque fois les impuretés précipitées, puis à précipiter la gamma-globuline et à l'isoler à des températures comprises entre - 6 et + 20 degrés C à un pH de 7 à 8,2, soit par addition de polyéthylène-glycol jusqu'à une concentration de 12 % (poids/volume), soit par addition d'éthanol jusqu'à une concentration de 25 % (volume/volume). Cette nouvelle gamma-globuline convient très bien à l'injection intraveineuse.
FR7736336A 1976-12-03 1977-12-02 Gamma-globuline injectable par voie intraveineuse Granted FR2372841A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/747,063 US4124576A (en) 1976-12-03 1976-12-03 Method of producing intravenously injectable gamma globulin
KR7702742A KR810001001B1 (ko) 1976-12-03 1977-11-25 정맥 주사용 감마 글로부린의 제조방법

Publications (2)

Publication Number Publication Date
FR2372841A1 true FR2372841A1 (fr) 1978-06-30
FR2372841B1 FR2372841B1 (fr) 1981-07-10

Family

ID=26626069

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736336A Granted FR2372841A1 (fr) 1976-12-03 1977-12-02 Gamma-globuline injectable par voie intraveineuse

Country Status (25)

Country Link
US (1) US4124576A (fr)
JP (1) JPS6016407B2 (fr)
KR (1) KR810001001B1 (fr)
AR (1) AR215037A1 (fr)
AT (1) AT361119B (fr)
AU (1) AU516176B2 (fr)
BE (1) BE861463A (fr)
CA (1) CA1100872A (fr)
CH (1) CH640140A5 (fr)
DE (1) DE2751717A1 (fr)
DK (1) DK529377A (fr)
ES (1) ES464681A1 (fr)
FI (1) FI60022C (fr)
FR (1) FR2372841A1 (fr)
GB (1) GB1558943A (fr)
GR (1) GR64099B (fr)
HK (1) HK50581A (fr)
IE (1) IE46104B1 (fr)
IT (1) IT1092178B (fr)
NL (1) NL7713362A (fr)
NZ (1) NZ185846A (fr)
PT (1) PT67350B (fr)
SE (1) SE443294B (fr)
YU (1) YU41084B (fr)
ZA (1) ZA777185B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2436604A1 (fr) * 1978-09-19 1980-04-18 Immuno Ag Appareil d'impression avec traitement thermique du papier imprime
FR2513640A1 (fr) * 1981-09-29 1983-04-01 Fujizoki Seiyaku Kk Procede de preparation d'une composition de gamma globuline qui convient pour l'administration intraveineuse et composition obtenue par ce procede
EP0092186A2 (fr) * 1982-04-16 1983-10-26 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Méthode de préparation de gamma-globuline convenant à l'administration intraveineuse

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
JPS5625114A (en) * 1979-08-07 1981-03-10 Green Cross Corp:The Preparation of human gamma globulin
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
JPS5732228A (en) * 1980-08-05 1982-02-20 Green Cross Corp:The Preparation of immunoglobulin usable for intravenous injection
JPS57203017A (en) * 1981-06-09 1982-12-13 Fujirebio Inc Purifying method of immunoglobulin
JPS5821623A (ja) * 1981-07-28 1983-02-08 Tetsuzo Sugizaki 抗原抗体複合体沈着疾患治療剤
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
DE3173666D1 (en) * 1981-10-29 1986-03-13 Green Cross Corp Process for preparing immunoglobulin suitable for intravenous injection
ATE19735T1 (de) * 1982-02-08 1986-05-15 Schweiz Serum & Impfinst Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung.
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
JPS59157017A (ja) * 1983-02-25 1984-09-06 Green Cross Corp:The 静脈投与用γ−グロブリン製剤
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
US4719290A (en) * 1983-09-02 1988-01-12 Armour Pharmaceutical Corporation Composition of intravenous immune globulin
DE3483784D1 (de) * 1984-07-07 1991-01-31 Woelm Pharma Gmbh & Co Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
GB8519848D0 (en) * 1985-08-07 1985-09-11 Schweiz Rotes Kreuz Treatment of chronic inflammatory disease
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
JPH0452190Y2 (fr) * 1986-07-30 1992-12-08
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンa製剤の製造法
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
JPH07285609A (ja) * 1994-04-18 1995-10-31 Japan Steel & Tube Constr Co Ltd ごみ真空輸送装置の閉塞解除運転方法及びその装置
DK2261230T3 (en) 2002-09-11 2017-06-12 Chugai Pharmaceutical Co Ltd Method of Protein Purification.
TWI532498B (zh) 2008-03-17 2016-05-11 巴克斯特保健公司 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
IN2012DN03219A (fr) 2009-09-17 2015-10-23 Baxter Healthcare Sa
WO2015137530A1 (fr) 2014-03-11 2015-09-17 주식회사 녹십자홀딩스 Procédé de purification d'immunoglobuline
CA2941232C (fr) 2014-03-11 2020-08-25 Green Cross Holdings Corporation Procede de purification d'immunoglobuline
KR101657690B1 (ko) 2015-06-05 2016-09-19 주식회사 녹십자홀딩스 혈장 유래 b형 간염 사람 면역글로불린 제제의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520076A (en) * 1947-07-18 1950-08-22 John W Williams Process for separating and recovering globulins from blood plasmas
NL286954A (fr) * 1962-01-03
SE348942B (fr) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (fr) * 1973-01-13 1974-09-25
US3808189A (en) * 1973-03-15 1974-04-30 American Cyanamid Co Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol
FR2267115B1 (fr) * 1974-04-12 1977-11-10 Merieux Inst
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
JPS5193935A (fr) * 1975-02-15 1976-08-18
CA1064396A (fr) * 1975-02-18 1979-10-16 Myer L. Coval Precipitation fractionnee de la gamma globuline a l'aide de polyethylene glycol

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2436604A1 (fr) * 1978-09-19 1980-04-18 Immuno Ag Appareil d'impression avec traitement thermique du papier imprime
FR2513640A1 (fr) * 1981-09-29 1983-04-01 Fujizoki Seiyaku Kk Procede de preparation d'une composition de gamma globuline qui convient pour l'administration intraveineuse et composition obtenue par ce procede
EP0092186A2 (fr) * 1982-04-16 1983-10-26 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Méthode de préparation de gamma-globuline convenant à l'administration intraveineuse
EP0092186A3 (en) * 1982-04-16 1984-07-18 Fujirebio Kabushiki Kaisha Also Trading As Fujirebio Inc. Method of preparing gamma globulin suitable for intravenous administration

Also Published As

Publication number Publication date
FI60022B (fi) 1981-07-31
KR810001001B1 (ko) 1981-08-29
FI60022C (fi) 1981-11-10
GB1558943A (en) 1980-01-09
GR64099B (en) 1980-01-22
SE443294B (sv) 1986-02-24
PT67350A (en) 1977-12-01
FR2372841B1 (fr) 1981-07-10
IE46104B1 (en) 1983-02-23
ES464681A1 (es) 1978-09-01
JPS6016407B2 (ja) 1985-04-25
BE861463A (fr) 1978-06-02
PT67350B (en) 1979-10-10
ATA833377A (de) 1980-07-15
IT1092178B (it) 1985-07-06
CA1100872A (fr) 1981-05-12
YU41084B (en) 1986-12-31
DE2751717A1 (de) 1978-07-13
HK50581A (en) 1981-10-30
DK529377A (da) 1978-06-04
NL7713362A (nl) 1978-06-06
DE2751717C2 (fr) 1991-01-24
US4124576A (en) 1978-11-07
IE46104L (en) 1978-06-03
FI773477A (fi) 1978-06-04
ZA777185B (en) 1979-08-29
AU3119677A (en) 1979-06-07
AR215037A1 (es) 1979-08-31
NZ185846A (en) 1980-10-24
SE7713719L (sv) 1978-06-04
AU516176B2 (en) 1981-05-21
AT361119B (de) 1981-02-25
CH640140A5 (de) 1983-12-30
JPS5372816A (en) 1978-06-28
YU276577A (en) 1983-01-21

Similar Documents

Publication Publication Date Title
FR2372841A1 (fr) Gamma-globuline injectable par voie intraveineuse
SU576898A3 (ru) Способ снижени реактогенности гамма-глобулина
FR2449729A1 (fr) Procede de recuperation d'uranium
DE3236126A1 (de) Verfahren zur herstellung von zur intravenoesen verabreichung geeignetem (gamma)-globulin
US3497492A (en) Preparation of placental albumin
Kunitz An improved method for isolation of crystalline pyrophosphatase from baker's yeast
SE7407882L (sv) Sett att behandla vetskor innehallande blodkroppar.
US4197238A (en) Method of preparation of human albumin using polyethylene glycol
ES298272A1 (es) Procedimiento para la obtención de una nueva proteína
Brink et al. PITUITARY HORMONES. III. 1 THE ISOLATION OF CORTICOTROPIN-B
GB1476103A (en) Method for the separation of chlorophyll
SE7906137L (sv) Rening av faktor viii
US2476085A (en) Purification of subtilin
ATE39324T1 (de) Blutfraktionierung.
SU1127525A3 (ru) Способ выделени альбумина
US2974088A (en) Method of preparing growth hormone
ES416726A1 (es) Procedimiento para aislar un antigeno de polipeptido aso- ciado con el cancer.
Ross et al. Molecular Compounds. VII. Interactions between 1, 3, 5-Trinitrobenzene and Pyridine-N-Oxides in Chloroform Solution
SU702003A1 (ru) Способ очистки солей высших четвертичных аммониевых оснований содержащих от 20 до 50 атомов углерода
US4749794A (en) Manufacturing of benzydamine purification of benzydamine using steam distillation
Molloy Determination of Selenium in Soils by a Modified Fluorimetric Method
GB1144806A (en) Production of purified wet process phosphoric acid from phosphate rock
SU587940A1 (ru) Способ получени фламина
US1586116A (en) Process for the production of glucosides of digitalis
Anghileri Oleic Acid labelled with Iodine-I3I, and Triolein De-iodination in vitro

Legal Events

Date Code Title Description
ST Notification of lapse